Michael Vasconcelles
Chief Tech/Sci/R&D Officer bei IMMUNOGEN, INC.
Profil
Michael J.
Vasconcelles currently works at Molecular Partners AG, as Independent Non-Executive Director from 2020, Molecular Partners, Inc., as Director, ImmunoGen, Inc., as Chief Medical Officer from 2023, Frazier Management LLC, as Senior Advisor from 2019, American Society of Clinical Oncology, Inc., as Member, and American Society of Hematology, as Member.
Dr. Vasconcelles also formerly worked at American Cancer Society New England Division, Inc., as Director, Personalized Medicine Coalition, as Director, Magenta Therapeutics, Inc., as Independent Director, Genzyme Corp., as Group VP & Head-Global Therapeutic Area from 2000 to 2012, Cogent Biosciences, Inc., as Chief Medical Officer from 2015 to 2019, Sanofi SA, as Global Therapeutic Area Head-Transplant & Oncology, Takeda Pharmaceuticals International, Inc., as Senior VP & Head-Oncology Therapy Area Unit from 2012 to 2015, Flatiron Health, Inc., as Chief Medical Officer-Research & Regulatory, and Sanofi Oncology, as Head-Personalized Medicine & Companion Diagnostics.
Dr. Vasconcelles received his undergraduate degree from Northwestern University and doctorate degree from Feinberg School of Medicine.
Aktive Positionen von Michael Vasconcelles
Unternehmen | Position | Beginn |
---|---|---|
MOLECULAR PARTNERS AG | Director/Board Member | 29.04.2020 |
IMMUNOGEN, INC. | Chief Tech/Sci/R&D Officer | 04.01.2023 |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Consultant / Advisor | 01.01.2019 |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Director/Board Member | - |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Corporate Officer/Principal | - |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Michael Vasconcelles
Unternehmen | Position | Ende |
---|---|---|
COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 15.07.2019 |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The private company is based in Deerfield, IL. | Corporate Officer/Principal | 01.10.2015 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2012 |
░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
░░░░░░ ░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Michael Vasconcelles
Northwestern University | Undergraduate Degree |
Feinberg School of Medicine | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
IMMUNOGEN, INC. | Health Technology |
COGENT BIOSCIENCES, INC. | Health Technology |
MOLECULAR PARTNERS AG | Health Technology |
Private Unternehmen | 12 |
---|---|
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Management LLC (Frazier Healthcare Partners) is a venture capital subsidiary of Frazier & Co Inc. founded in 1991. The firm is headquartered in Seattle, Washington. | Finance |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
American Society of Clinical Oncology, Inc.
American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Health Services |
American Society of Hematology
American Society of Hematology Miscellaneous Commercial ServicesCommercial Services American Society of Hematology provides the most current practice tools, clinical support and educational products needed in hematology. The firm offers educational products and services for clinicians and scientists. The company is headquartered in Washington, DC. | Commercial Services |
American Cancer Society New England Division, Inc. | |
Sanofi SA | Health Technology |
Personalized Medicine Coalition
Personalized Medicine Coalition Miscellaneous Commercial ServicesCommercial Services The Personalized Medicine Coalition promotes the understanding and adoption of personalized medicine concepts, services, and products. The private company is based in Washington and was founded by Patrick F. Terry. | Commercial Services |
Takeda Pharmaceuticals International, Inc.
Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The private company is based in Deerfield, IL. | Commercial Services |
Flatiron Health, Inc.
Flatiron Health, Inc. Packaged SoftwareTechnology Services Flatiron Health, Inc. develops health care technology. Its OncologyCloud platform allows cancer centers, physicians and life science companies to gain actionable insights from clinical, practice management and billing data. The firm's software platform accelerates personalized medicine and research by applying advanced analytics to electronic patient care data documented by physicians. The company was founded by Nathaniel S. Turner and Zachary W. Weinberg in 2012 and is headquartered in New York, NY. | Technology Services |
Magenta Therapeutics, Inc.
Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The private company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
Sanofi Oncology
Sanofi Oncology Miscellaneous Commercial ServicesCommercial Services Sanofi Oncology provides Salesforce and strategic consulting services. | Commercial Services |